OCC Reports Q1 Revenue of $16.4M
Reports Q1 revenue $16.4M vs. $15.7M last year. CEO Neil Wilkin said, "OCC is off to a solid start in fiscal year 2026. During the first quarter, we delivered net sales and gross profit growth, largely driven by increased demand across our enterprise and specialty markets, and the positive impact of our operating leverage. As we begin our second quarter, we are seeing growing momentum in our targeted markets, including our data center market. Our sales order backlog and forward load increased more than 50% to $10.4M compared to the same prior fiscal year period, and we expect to continue to build on this momentum. We are confident that OCC is well positioned for growth during FY26 and, as always, we remain focused on disciplined execution to drive value for our customers and shareholders".
Trade with 70% Backtested Accuracy
Analyst Views on OCC
About OCC
About the author


- Dycom Industries Surge: Dycom Industries saw its shares soar by up to 35%, reporting a non-GAAP EPS of $4.42, beating estimates by $1.70, with revenue of $1.96 billion exceeding expectations by $290 million, indicating accelerating demand for hyperscale data center construction and fiber deployments, thus boosting market confidence in its future growth.
- Electrical Infrastructure in Demand: As investors focus on AI-related electrical infrastructure, companies like Vicor and Shoals Technologies Group also reached 52-week highs, with Vicor viewed as a leveraged play on AI server power density and Shoals favored for its supply of electrical balance-of-system components for solar projects, reflecting ongoing market interest in electrification and grid-related firms.
- Transportation Stocks Rebound: Transportation stocks such as FedEx, Heartland Express, and Marten Transport also hit 52-week highs, suggesting a growing expectation of recovery in freight demand after years of recession, with FedEx benefiting from ongoing cost-cutting initiatives and expectations of improved industrial activity in the second half of the year.
- Market Trend Shift: This rally indicates a shift in investor focus towards companies linked to infrastructure buildouts, power demand, and physical-world capacity, highlighting a renewed interest in traditional industrial and transportation sectors after years dominated by software and asset-light businesses.
- New Additions: Optical Cable (OCC) and Network-1 Technologies (NTIP) are set to join the FTSE Russell Microcap Index on June 26, which is expected to enhance their market visibility and investment appeal.
- Companies Exiting: Vistance Networks (VISN), Applied Optoelectronics (AAOI), SurgePays (SURG), and Digi International (DGII) will leave the index, potentially leading to decreased liquidity and diminished investor confidence.
- Market Reaction Anticipation: The changes will take effect after US markets close, prompting market participants to closely monitor the impact of these adjustments on the stock prices and portfolios of the affected companies, particularly the negative implications for those exiting the index.
- Industry Dynamics: The reconstitution of the FTSE Russell Microcap Index reflects the dynamic changes within the communications services sector, prompting investors to consider how these shifts may affect overall industry performance and future investment strategies.
- Significant Revenue Growth: Orthocell reported $3.2 million in revenue for the March 2026 quarter, consistent with the previous period, while year-to-date revenue reached $9.4 million, reflecting a 45% increase, indicating strong commercial expansion across multiple markets.
- Accelerating US Market: Sales of Remplir in the US hit $300,000, with $170,000 generated in March alone, suggesting a surge in demand that is expected to enhance the company's market coverage across 16 states, further tapping into its $1.6 billion addressable market.
- Robust Cash Position: At the end of the quarter, Orthocell held $7.8 million in cash and cash equivalents, alongside $40.2 million in term deposits, ensuring a strong financial foundation for ongoing commercial execution, supporting future R&D and marketing efforts.
- Clinical Application Expansion: The company secured approval for Remplir's use across US Department of Defense hospital networks, comprising 221 medical centers, and has already completed the first surgical case, highlighting the effectiveness of its commercial strategy and surgeon engagement activities.
- Sales Growth: OCC's net sales increased by 4.4% year-over-year to $16.4 million in Q1, indicating stable performance in the market despite seasonal challenges.
- Gross Profit Improvement: Gross profit rose by 16.1% to $5.4 million, with gross margin increasing to 32.7%, reflecting positive progress in cost control and product pricing strategies.
- Backlog Increase: Sales order backlog surged over 50% to $10.4 million, demonstrating strong customer demand, particularly in the data center sector, which signals potential future sales growth.
- Net Loss Situation: Despite growth in sales and gross profit, OCC recorded a net loss of $398,000, highlighting challenges in managing SG&A expenses, particularly due to rising employee and shipping costs.
- Earnings Report: Optical Cable Corporation reported a GAAP EPS of -$0.05 for Q1, indicating challenges in profitability; however, revenue increased by 4.5% year-over-year to $16.4 million, suggesting improved sales capabilities in the market.
- Revenue Growth: Despite the negative EPS, the 4.5% year-over-year revenue growth reflects stability in product demand, yet ongoing losses may undermine investor confidence in the company's financial health.
- Market Outlook: The future market performance of Optical Cable Corporation remains to be seen, particularly regarding the recovery of profitability, as investors will closely monitor subsequent earnings reports and strategic initiatives.
- Analyst Ratings: According to Seeking Alpha's Quant Rating, the financial performance of Optical Cable Corporation may influence its standing among investors, with future financial transparency and profitability being critical factors for assessment.
- Cash Reserves Boost: Orthocell confirmed receipt of a $3 million R&D tax refund, elevating its cash balance to $49.6 million, which enhances the company's financial flexibility and supports future R&D and market initiatives.
- Accelerated Product Commercialization: The company is focused on accelerating the commercialization of its nerve repair product Remplir™ across the Americas and Asia Pacific, leveraging a debt-free balance sheet and ongoing investment in clinical evidence to strengthen its market position.
- Policy Support for Innovation: CEO Paul Anderson emphasized that the Australian Federal Government's R&D tax incentive program provides significant economic incentives, encouraging increased investment in R&D, thereby driving innovation and market growth.
- Significant Market Potential: Orthocell targets a total addressable market exceeding $3.5 billion in selected jurisdictions and plans to continue investing to support the uptake of Remplir™, while maintaining a strong funding position to navigate market challenges.









